Suzhou Fushilai Pharmaceutical Co., Ltd

Suzhou Fujilai Pharmaceutical Co., Ltd. mainly produces three major products: lipoic acid series, carnosine series, and phosphatidylcholine series, all of which are encouraged "biomedicine" high-tech products. The products are mainly used in the fields of medicine, dietary supplements and cosmetics, and have significant effects in antioxidants, delaying aging, and alleviating diabetic neuropathy. Products are mainly exported and have been exported to foreign markets such as Europe, America, and Southeast Asia. The domestic market share of lipoic acid APIs ranks among the top, and it has established long-term strategic cooperative relationships with important customers at home and abroad. Over the years, the company has focused on source pollution reduction, process pollution reduction and the adoption of advanced and effective end-of-pipe treatment to achieve micro-discharge of wastewater and total pollution control. The company strictly carries out production work in accordance with product-related quality management systems. In the field of raw materials, it has passed GMP certification in many countries, such as China, Japan, South Korea, etc., and in the field of dietary supplements, it has passed on-site inspections by the US FDA.